Skip to main content
. Author manuscript; available in PMC: 2007 Aug 23.
Published in final edited form as: Cardiovasc Res. 2007 Feb 12;74(3):377–387. doi: 10.1016/j.cardiores.2007.01.021

TABLE 1.

Body weight and hematocrit

GROUP n BW BEFORE (g) BW AFTER (g) HCT (%)
LAC 5 300 ± 18 380 ± 17 50 ± 1
LAD 5 308 ± 14 279 ± 12* 49 ± 1
HAC 5 336 ± 16 352 ± 14* 69 ± 2*
HAD 0.3 4 309 ± 2 288 ± 8 * 64 ± 1*
HAD 1 9 311 ± 3 251 ± 8*# 66 ± 2*

Values are means ± SE. BW, body weight before (BEFORE) and after (AFTER) the treatment; HCT, hematocrit after the treatment; LAC, low altitude untreated control; LAD, low altitude 1%DHEA treated; HAC, high altitude untreated control; HAD 0.3 and HAD 1, high altitude 0.3 and 1% DHEA treated groups, respectively.

*

P<0.05 vs. LAC;

P<0.05 vs. HAC;

#

P<0.05 vs. HAD 0.3.